Shilpa Medicare Share Price
965.80+9.65 (+1.01%)
+128.74% past 1 Year
Shilpa Medicare Limited (SML) started its operations as API manufacturer way back in 1987 at Raichur, Karnataka- India. The commercial production in the SML was started in November 1989. Presently,
Corporate filings & documents
Announcements
Dispatch of letter to shareholders whose e-mail addresses are not registered with Company/ Registrar & Transfer Agent/ Depository Participants.
2 weeks agoDispatch of letter to shareholders whose e-mail addresses are not registered with Company/ Registrar & Transfer Agent/ Depository Participants.
2 weeks agoDisclosure under Reg.30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 weeks agoDisclosure under Reg.30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 weeks agoDividend Update
2 weeks agoDividend Update
2 weeks agoNewspaper Publication
3 weeks agoNewspaper Publication
3 weeks agoAnnual Report of Shilpa Medicare Limited for the FY 2025-26
3 weeks agoAnnual Report of Shilpa Medicare Limited for the FY 2025-26
3 weeks ago39th Annual General Meeting Notice
3 weeks ago39th Annual General Meeting Notice
3 weeks agoQ1FY27 earnings conference call transcript
3 weeks agoQ1FY27 earnings conference call transcript
3 weeks agoAudio link of the Investor Conference call for Q1 FY27
4 weeks agoAudio link of the Investor Conference call for Q1 FY27
4 weeks agoInvestor Presentation for Q1FY27
1 month agoInvestor Presentation for Q1FY27
1 month agoThe record date for determining the shareholders entitled for payment of final dividend for FY 2025-26 if declared at the 39th AGM is Friday 4th September 2026.
1 month agoThe record date for determining the shareholders entitled for payment of final dividend for FY 2025-26 if declared at the 39th AGM is Friday 4th September 2026.
1 month agoUnaudited standalone and consolidated Financial Results for the Quarter ended 30 June 2026
1 month agoUnaudited standalone and consolidated Financial Results for the Quarter ended 30 June 2026
1 month agoUnaudited Financial Results for the Quarter ended 30 June 2026
1 month agoUnaudited Financial Results for the Quarter ended 30 June 2026
1 month agoAppointment of Dr. Uday N. Harle as Chief Executive Officer of Shilpa Biologicals Private Limited a wholly owned subsidiary of Shilpa Medicare Limited w.e.f 03 August 2026. (Senior Managerial Personnel).
1 month agoAppointment of Dr. Uday N. Harle as Chief Executive Officer of Shilpa Biologicals Private Limited a wholly owned subsidiary of Shilpa Medicare Limited w.e.f 03 August 2026. (Senior Managerial Personnel).
1 month agoInvestor conference call for Q1-FY27 is scheduled to be held on 05 August 2026
1 month agoInvestor conference call for Q1-FY27 is scheduled to be held on 05 August 2026
1 month agoShilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Unaudited financial results for the Quarter ended 30 June 2026
1 month agoShilpa Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2026 inter alia to consider and approve Unaudited financial results for the Quarter ended 30 June 2026
1 month agoCredit Rating
1 month agoCredit Rating
1 month agoResignation of Dr. Sridevi Khambhampaty as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited material subsidiary of Shilpa Medicare Limited.
1 month agoResignation of Dr. Sridevi Khambhampaty as Chief Executive Officer (CEO) of Shilpa Biologicals Private Limited material subsidiary of Shilpa Medicare Limited.
1 month agoIntimation of Credit Rating
1 month agoIntimation of Credit Rating
1 month agoCertificate under Reg. 74(5) of SEBI (DP) Regulation 2018
1 month agoCertificate under Reg. 74(5) of SEBI (DP) Regulation 2018
1 month agoShilpa Biologicals Pvt Ltd a wholly owned subsidiary of Shilpa Medicare Limited enters into a Co-development and supply agreement with Orion Corporation Finland
2 months agoShilpa Biologicals Pvt Ltd a wholly owned subsidiary of Shilpa Medicare Limited enters into a Co-development and supply agreement with Orion Corporation Finland
2 months agoNewspaper Publication
2 months agoNewspaper Publication
2 months agoIntimation of Closure of Trading Window
2 months agoIntimation of Closure of Trading Window
2 months agoShilpa Biologicals Pvt Ltd a material subsidiary of Shilpa Medicare Ltd and M/s Sartorius Stedim India Pvt Ltd have entered into a settlement agreement
2 months agoShilpa Biologicals Pvt Ltd a material subsidiary of Shilpa Medicare Ltd and M/s Sartorius Stedim India Pvt Ltd have entered into a settlement agreement
2 months agoShilpa Medicare Limited has informed the exchange about the copy of news paper publication.
2 months agoShilpa Medicare Limited has informed the exchange about the copy of news paper publication.
2 months agoPress Release on announcement of commissioning of a state-of-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility by Shilpa Biologicals Private Limited a material subsidiary of Shilpa Medicare Ltd.
2 months agoPress Release on announcement of commissioning of a state-of-art Antibody-Drug Conjugate (ADC) GMP Manufacturing Facility by Shilpa Biologicals Private Limited a material subsidiary of Shilpa Medicare Ltd.
2 months agoAnnual reports
Concalls & investor presentations
Aug 2026
May 2026
Feb 2026
Aug 2025
May 2025
Feb 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Nov 2024
ConcallPresentation
Nov 2024
ConcallPresentation
Aug 2024
ConcallPresentation
Aug 2024
ConcallPresentation
May 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Aug 2022
ConcallPresentation
Feb 2022
ConcallPresentation
Oct 2021
ConcallPresentation
Aug 2021
ConcallPresentation
May 2021
ConcallPresentation
Feb 2021
ConcallPresentation
Nov 2020
ConcallPresentation
Corporate Actions
Date
Type
Details
2026-09-04
Dividend
0.6
2025-10-03
Bonus
1:1
2025-09-17
Dividend
1.0
2021-09-20
Dividend
1.1
2020-03-16
Dividend
1.1
2019-09-12
Dividend
1.0
2018-03-01
Dividend
0.7
2017-03-21
Dividend
0.6
2016-03-28
Dividend
0.6
2015-11-06
Split
2:1
2015-09-16
Dividend
1.1
2014-09-11
Dividend
1.0
2012-09-17
Dividend
0.9
2011-09-15
Dividend
0.8
2010-09-16
Dividend
0.7
Company details
Registered office
Shilpa House #12-6-214/ A1 Hyderabad Road Raichur Karnataka PIN: 584135 Tel No: 08532-238704 Fax No: 08532-238876 Email: [email protected] Internet: www.vbshilpa.com
Registrars
Karvy Selenium Tower B, Plot 31-32Gachibowli,Financial District, NanakramgudaHyderabad – 500032Tel. No. 040 67161500Fax. No. 040 23001153E-mail: [email protected]: www.karvy.comToll Free No. of exclusive Call Centre:1-800-345001 Karvy Selenium Tower B, Plot 31-32 Gachibowli,Financial District Nanakramguda PIN: Tel No: 040 - 67162222/18003094001 Fax No: NULL Email: [email protected] Internet: www.kfintech.com
Management
Ritu Tiwary, Company Secretary & Compliance Officer
Omprakash Inani, Chairman
Vishnukant Bhutada, Managing Director
Sharath Reddy Kalakota, Whole Time Director
Hetal Madhukant Gandhi, Non Executive Independent Director
Anita Bandyopadhyay, Non Executive Independent Woman Director
Ashraf Loutfy Abdelhamid Allam, Non Executive Independent Director
Details
BSE 530549
NSE SHILPAMED
ISIN INE790G01031